HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.

Abstract
beta-Thalassemia and sickle cell disease both display a great deal of phenotypic heterogeneity, despite being generally thought of as simple Mendelian diseases. The reasons for this are not well understood, although the level of fetal hemoglobin (HbF) is one well characterized ameliorating factor in both of these conditions. To better understand the genetic basis of this heterogeneity, we carried out genome-wide scans with 362,129 common SNPs on 4,305 Sardinians to look for genetic linkage and association with HbF levels, as well as other red blood cell-related traits. Among major variants affecting HbF levels, SNP rs11886868 in the BCL11A gene was strongly associated with this trait (P < 10(-35)). The C allele frequency was significantly higher in Sardinian individuals with elevated HbF levels, detected by screening for beta-thalassemia, and patients with attenuated forms of beta-thalassemia vs. those with thalassemia major. We also show that the same BCL11A variant is strongly associated with HbF levels in a large cohort of sickle cell patients. These results indicate that BCL11A variants, by modulating HbF levels, act as an important ameliorating factor of the beta-thalassemia phenotype, and it is likely they could help ameliorate other hemoglobin disorders. We expect our findings will help to characterize the molecular mechanisms of fetal globin regulation and could eventually contribute to the development of new therapeutic approaches for beta-thalassemia and sickle cell anemia.
AuthorsManuela Uda, Renzo Galanello, Serena Sanna, Guillaume Lettre, Vijay G Sankaran, Weimin Chen, Gianluca Usala, Fabio Busonero, Andrea Maschio, Giuseppe Albai, Maria Grazia Piras, Natascia Sestu, Sandra Lai, Mariano Dei, Antonella Mulas, Laura Crisponi, Silvia Naitza, Isadora Asunis, Manila Deiana, Ramaiah Nagaraja, Lucia Perseu, Stefania Satta, Maria Dolores Cipollina, Carla Sollaino, Paolo Moi, Joel N Hirschhorn, Stuart H Orkin, Gonçalo R Abecasis, David Schlessinger, Antonio Cao
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 105 Issue 5 Pg. 1620-5 (Feb 05 2008) ISSN: 1091-6490 [Electronic] United States
PMID18245381 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
Chemical References
  • BCL11A protein, human
  • Carrier Proteins
  • Nuclear Proteins
  • Repressor Proteins
  • Fetal Hemoglobin
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carrier Proteins (genetics)
  • Cohort Studies
  • Female
  • Fetal Hemoglobin (analysis, metabolism)
  • Gene Frequency
  • Genetic Linkage
  • Genome, Human
  • Humans
  • Italy
  • Male
  • Middle Aged
  • Nuclear Proteins (genetics)
  • Phenotype
  • Polymorphism, Single Nucleotide
  • Repressor Proteins
  • beta-Thalassemia (diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: